Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications
The gastrointestinal tract is involved in coronavirus disease 2019 (COVID-19) caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The gut microbiota has …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The gut microbiota has …
Antibody tests for identification of current and past infection with SARS‐CoV‐2
Background The diagnostic challenges associated with the COVID‐19 pandemic resulted in
rapid development of diagnostic test methods for detecting SARS‐CoV‐2 infection. Serology …
rapid development of diagnostic test methods for detecting SARS‐CoV‐2 infection. Serology …
Previous immunity shapes immune responses to SARS-CoV-2 booster vaccination and Omicron breakthrough infection risk
The heterogeneity of the SARS-CoV-2 immune responses has become considerably more
complex over time and diverse immune imprinting is observed in vaccinated individuals …
complex over time and diverse immune imprinting is observed in vaccinated individuals …
Accelerated waning of the humoral response to COVID-19 vaccines in obesity
Obesity is associated with an increased risk of severe Coronavirus Disease 2019 (COVID-
19) infection and mortality. COVID-19 vaccines reduce the risk of serious COVID-19 …
19) infection and mortality. COVID-19 vaccines reduce the risk of serious COVID-19 …
A potential association between obesity and reduced effectiveness of COVID‐19 vaccine‐induced neutralizing humoral immunity
Due to the adverse effects of obesity on host immunity, this study investigated the
effectiveness of COVID‐19 vaccines (BNT162b2, ChAdOx‐nCov‐2019, and mRNA‐1273) in …
effectiveness of COVID‐19 vaccines (BNT162b2, ChAdOx‐nCov‐2019, and mRNA‐1273) in …
SARS-CoV-2 infection, vaccination, and antibody response trajectories in adults: a cohort study in Catalonia
Background Heterogeneity of the population in relation to infection, COVID-19 vaccination,
and host characteristics is likely reflected in the underlying SARS-CoV-2 antibody …
and host characteristics is likely reflected in the underlying SARS-CoV-2 antibody …
[HTML][HTML] Seroprevalence of antibodies against SARS-CoV-2 and risk of COVID-19 in Navarre, Spain, May to July 2022
J Castilla, Ó Lecea, CM Salas, D Quílez… - …, 2022 - eurosurveillance.org
In Navarre, Spain, in May 2022, the seroprevalence of anti-nucleocapsid (N) and anti-spike
(S) antibodies of SARS-CoV-2 was 58.9% and 92.7%, respectively. The incidence of …
(S) antibodies of SARS-CoV-2 was 58.9% and 92.7%, respectively. The incidence of …
Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimens
Background Both infection and vaccination, alone or in combination, generate antibody and
T cell responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
T cell responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
Challenges in the detection of SARS-CoV-2: evolution of the lateral flow immunoassay as a valuable tool for viral diagnosis
SARS-CoV-2 is an emerging infectious disease of zoonotic origin that caused the
coronavirus disease in late 2019 and triggered a pandemic that has severely affected …
coronavirus disease in late 2019 and triggered a pandemic that has severely affected …
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immune responses and
infection outcomes were evaluated in 2,686 patients with varying immune-suppressive …
infection outcomes were evaluated in 2,686 patients with varying immune-suppressive …